AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO) and Astellas Pharma Inc. (YPH.BE) Announce Presentations of Tivozanib Clinical Data at 2013 American Society of Clinical Oncology Annual Meeting
5/16/2013 8:42:33 AM
More...
|
AstraZeneca PLC (AZN), Cubist Pharmaceuticals, Inc. (CBST), Astellas Pharma Inc. (YPH.BE) Said to Make Bids for Optimer Pharmaceuticals, Inc. (OPTR)
5/15/2013 8:19:07 AM
More...
|
Astellas Pharma Inc. (YPH.BE) Joins the National Pharmaceutical Council
5/14/2013 9:57:32 AM
More...
|
Astellas Pharma Inc. (YPH.BE) Shuts Down OSI Pharmaceuticals, Inc. (OSIP), Perseid in Restructuring of R&D Ops, Cuts 200 Jobs
5/14/2013 8:02:02 AM
More...
|
Astellas Pharma Inc. (YPH.BE) and Drais Pharmaceuticals Join Forces With $15 Million to Launch Virtual Co.
5/7/2013 7:59:27 AM
More...
|
FDA Committee Turns Down AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO)/Astellas Pharma Inc. (YPH.BE)'s Cancer Drug
5/3/2013 7:41:57 AM
More...
|
Astellas Pharma Inc. (YPH.BE), Medivation, Inc. (MDVN) Release: Positive CHMP Opinion for Xtandi ™ (Enzalutamide) in Advanced Prostate Cancer
4/26/2013 10:07:22 AM
More...
|
Astellas Pharma Inc. (YPH.BE), GlaxoSmithKline (GSK) Vie to Make "High Altitude" Anemia Pill
4/19/2013 10:53:24 AM
More...
|
Astellas Pharma Inc. (YPH.BE) Partners With CUOG to Advance Uro-Oncology Research in Canada
4/17/2013 10:01:11 AM
More...
|
Astellas Pharma Inc. (YPH.BE): New Hire Reinforces Global Compliance Structure
4/15/2013 9:45:50 AM
More...
|
|